The fact that only one patient exceeded the clinical threshold for depression and four patients for anxiety further reinforces the idea that NET disruptions are more fatigue‐specific, while mGluR5 dysfunction might reflect a shared neurochemical mechanism underlying both fatigue and mood disturbances. This evidence concerns the gene GRM5 and depressive disorder.